Widespread Microstructural White Matter Involvement in Amyotrophic Lateral Sclerosis: A Whole-Brain DTI Study

References

1. 1.↵
   1. Davidoff RA

   . The pyramidal tract. Neurology 1990;40:332–39

   FREE Full Text
2. 2.↵
   1. Ellis CM,
   2. Simmons A,
   3. Jones DK,
   4. et al

   . Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999;53:1051–58

   Abstract/FREE Full Text
3. 3.↵
   1. Basser PJ,
   2. Pierpaoli C

   . Microstructural and physiological features of tissues elucidated by quantitative-diffusion tensor MRI. J Magn Reson 1996;111:209–19

   CrossRefWeb of Science
4. 4.↵
   1. Toosy AT,
   2. Werring DJ,
   3. Orrell RW,
   4. et al

   . Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003;74:1250–57

   Abstract/FREE Full Text
5. 5.↵
   1. Graham JM,
   2. Papadakis N,
   3. Evans J,
   4. et al

   . Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004;63:2111–19

   Abstract/FREE Full Text
6. 6.↵
   1. Sach M,
   2. Winkler G,
   3. Glauche V,
   4. et al

   . Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004;127:340–50

   Abstract/FREE Full Text
7. 7.↵
   1. Iwata NK,
   2. Aoki S,
   3. Okabe S,
   4. et al

   . Evaluation of corticospinal tracts in ALS with diffusion tensor MRI and brainstem stimulation. Neurology 2008;70:528–32

   Abstract/FREE Full Text
8. 8.↵
   1. Metwalli NS,
   2. Benatar M,
   3. Nair G,
   4. et al

   . Utility of axial and radial diffusivity from diffusion tensor MRI as markers of neurodegeneration in amyotrophic lateral sclerosis. Brain Res 2010;1348:156–64

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Agosta F,
   2. Pagani E,
   3. Petrolini M,
   4. et al

   . Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: a diffusion tensor MR imaging tractography study. AJNR Am J Neuroradiol 2010;31:1457–61

   Abstract/FREE Full Text
10. 10.↵
    1. Ciccarelli O,
    2. Behrens TE,
    3. Altmann DR,
    4. et al

    . Probabilistic diffusion tractography: a potential tool to assess the rate of disease progression in amyotrophic lateral sclerosis. Brain 2006;129:1859–71

    Abstract/FREE Full Text
11. 11.↵
    1. Sage CA,
    2. Peeters RR,
    3. Gorner A,
    4. et al

    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007;34:486–99

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Thivard L,
    2. Pradat PF,
    3. Lehéricy S,
    4. et al

    . Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J Neurol Neurosurg Psychiatry 2007;78:889–92

    Abstract/FREE Full Text
13. 13.↵
    1. Geser F,
    2. Martinez-Lage M,
    3. Robinson J,
    4. et al

    . Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 2009;66:180–89

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Abe O,
    2. Yamada H,
    3. Masutani Y,
    4. et al

    . Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed 2004;17:411–16

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Agosta F,
    2. Pagani E,
    3. Rocca MA,
    4. et al

    . Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability. Hum Brain Mapp 2007;28:1430–38

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Johansen-Berg H,
    4. et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Sage CA,
    2. Van Hecke W,
    3. Peeters R,
    4. et al

    . Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009;30:3657–75

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Ciccarelli O,
    2. Behrens TE,
    3. Johansen-Berg H,
    4. et al

    . Investigation of white matter pathology in ALS and PLS using tract-based spatial statistics. Hum Brain Mapp 2009;30:615–24

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Filippini N,
    2. Douaud G,
    3. Mackay CE,
    4. et al

    . Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 2010;75:1645–52

    Abstract/FREE Full Text
20. 20.↵
    1. Senda J,
    2. Kato S,
    3. Kaga T,
    4. et al

    . Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study. Amyotroph Lateral Scler 2011;12:59–69

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Hua K,
    2. Zhang J,
    3. Wakana S,
    4. et al

    . Tract probability maps in stereotaxic spaces: analysis of white matter anatomy and tract-specific quantification. Neuroimage 2008;39:336–47

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Wakana S,
    2. Caprihan A,
    3. Panzenboeck MM,
    4. et al

    . Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage 2007;36:630–44

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Brooks BR,
    2. Miller RG,
    3. Swash M,
    4. et al

    . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–99

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Cedarbaum JM,
    2. Stambler N,
    3. Malta E,
    4. et al

    . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function: BDNF ALS Study Group (Phase III). J Neurol Sci 1999;169:13–21

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Kaufmann P,
    2. Pullman SL,
    3. Shungu DC,
    4. et al

    . Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 2004;62:1753–57

    Abstract/FREE Full Text
26. 26.↵
    1. Grace J,
    2. Stout JC,
    3. Malloy PF

    . Assessing frontal lobe behavioral syndromes with the frontal lobe personality scale. Assessment 1999;6:269–84

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Nishihira Y,
    2. Tan CF,
    3. Toyoshima Y,
    4. et al

    . Sporadic amyotrophic lateral sclerosis: widespread multisystem degeneration with TDP-43 pathology in a patient after long-term survival on a respirator. Neuropathology 2009;29:689–96

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Nishihira Y,
    2. Tan CF,
    3. Onodera O,
    4. et al

    . Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 2008;116:169–82

    CrossRefPubMed
29. 29.↵
    1. Eisen AA,
    2. Shaw PJ

    1. Ince PG,
    2. Wharton SB

    . Cytopathology of the motor neuron. In: Eisen AA, Shaw PJ eds. Motor Neuron Disorders and Related Diseases: Handbook of Clinical Neurology. 3rd Series. Amsterdam, the Netherlands: Elsevier; 2007:89–119
30. 30.↵
    1. Clement AM,
    2. Nguyen MD,
    3. Roberts EA,
    4. et al

    . Wildtype non-neuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003;302:113–17

    Abstract/FREE Full Text
31. 31.↵
    1. Chang JL,
    2. Lomen-Hoerth C,
    3. Murphy J,
    4. et al

    . A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 2005;65:75–80

    Abstract/FREE Full Text
32. 32.↵
    1. De Stefano N,
    2. Iannucci G,
    3. Sormani MP,
    4. et al

    . MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol 2002;249:1072–77

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Brownell B,
    2. Oppenheimer DR,
    3. Hughes JT

    . The central nervous system in motor neuron disease. J Neurol Neurosurg Psychiatry 1970;33:338–57

    Abstract/FREE Full Text
34. 34.↵
    1. Smith MC

    . Nerve fibre degeneration in the brain in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1960;23:269–82

    FREE Full Text
35. 35.↵
    1. Chao YP,
    2. Cho KH,
    3. Yeh CH,
    4. et al

    . Probabilistic topography of human corpus callosum using cytoarchitectural parcellation and high angular resolution diffusion imaging tractography. Hum Brain Mapp 2009;30:3172–87

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Matsuoka T,
    2. Fujii N,
    3. Kondo A,
    4. et al

    . An autopsied case of sporadic adult-onset amyotrophic lateral sclerosis with FUS-positive basophilic inclusions. Neuropathology 2011;31:71–76

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Tedeschi G,
    2. Trojsi F,
    3. Tessitore A,
    4. et al

    . Interaction between aging and neurodegeneration in amyotrophic lateral sclerosis. Neurobiol Aging 2012;33:886–98

    CrossRefPubMed
38. 38.↵
    1. Song SK,
    2. Sun SW,
    3. Ramsbottom MJ,
    4. et al

    . Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002;17:1429–36

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Song SK,
    2. Yoshino J,
    3. Le TQ,
    4. et al

    . Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26:132–40

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Sullivan EV,
    2. Rohlfing T,
    3. Pfefferbaum A

    . Quantitative fiber tracking of lateral and interhemispheric white matter systems in normal aging: relations to timed performance. Neurobiol Aging 2010;31:464–81

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Pfefferbaum A,
    2. Adalsteinsson E,
    3. Sullivan EV

    . Dysmorphology and microstructural degradation of the corpus callosum: interaction of age and alcoholism. Neurobiol Aging 2006;27:994–1009

    CrossRefPubMedWeb of Science
42. 42.↵
    1. Turner MR,
    2. Wicks P,
    3. Brownstein CA,
    4. et al

    . Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2011;82:853–54

    Abstract/FREE Full Text
43. 43.↵
    1. Hatazawa J,
    2. Brooks RA,
    3. Dalakas MC,
    4. et al

    . Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study. J Comput Assist Tomogr 1988;12:630–36

    PubMedWeb of Science
44. 44.↵
    1. Rule RR,
    2. Schuff N,
    3. Miller RG,
    4. et al

    . Gray matter perfusion correlates with disease severity in ALS. Neurology 2010;74:821–27

    Abstract/FREE Full Text
45. 45.↵
    1. Swash M,
    2. Scholtz CL,
    3. Vowles G,
    4. et al

    . Selective and asymmetric vulnerability of corticospinal and spinocerebellar tracts in motor neuron disease. J Neurol Neurosurg Psychiatry 1988;51:785–89

    Abstract/FREE Full Text
46. 46.↵
    1. Wang S,
    2. Poptani H,
    3. Woo JH,
    4. et al

    . Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 2006;239:831–38. Epub 2006 Apr 26

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Murphy J,
    2. Henry R,
    3. Lomen-Hoerth C

    . Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol 2007;64:330–34

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Abrahams S,
    2. Goldstein LH,
    3. Suckling J,
    4. et al

    . Frontotemporal white matter changes in amyotrophic lateral sclerosis. J Neurol 2005;252:321–31

    CrossRefPubMedWeb of Science
49. 49.↵
    1. Whitwell JL,
    2. Avula R,
    3. Senjem ML,
    4. et al

    . Gray and white matter water diffusion in the syndromic variants of frontotemporal dementia. Neurology 2010;74:1279–87

    Abstract/FREE Full Text